Form 424B2 JPMORGAN CHASE & CO
September 10, 2026
Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2)
JPMorgan Chase Financial Company LLCStructured Investments
$571,000
Digital... (continue reading...)
Form 424B2 CITIGROUP INC
The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
Form 4 Anixa Biosciences Inc For: Sep 10 Filed by: KUMAR AMIT
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 424B2 JPMORGAN CHASE & CO
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not
an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated September 11, 2026
September , 2026 Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2)
Pricing supplement to product supplement no. 3-I dated April... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 PARK OHIO HOLDINGS CORP For: Sep 11 Filed by: WERT JAMES W
-
Form 497K FRANKLIN STRATEGIC SERIE
-
Form 144 DEXCOM INC Filed by: AUGUSTINOS NICHOLAS
-
Form 6-K Western Copper & Gold For: Sep 14
-
Form 497 FRANKLIN STRATEGIC SERIE
-
Form 4 Gabelli Healthcare & For: Sep 11 Filed by: Saba Capital Management, L.P.
-
Form 424B3 Medicus Pharma Ltd.
-
Form 4 PIMCO Dynamic Income For: Sep 10 Filed by: Saba Capital Management, L.P.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K NewtekOne, Inc. For: Sep 14
-
Form D/A Moorstone Structured
-
Form 144 Essent Group Ltd. Filed by: KASMAR ROY JAMES
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K Mako Mining Corp. For: Sep 14
-
Form 4 BlackRock ESG Capital For: Sep 10 Filed by: Saba Capital Management, L.P.
-
Form 6-K BHP Group Ltd For: Sep 14
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Nova Select, LP
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D/A Moorstone Structured
-
Form ARS All In FutureTech Allian For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K Biofrontera Inc. For: Sep 14
-
Form D Riva at Chalco, LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-4/A Marine Thinking Inc. Filed by: Eureka Acquisition Corp
-
Form 8-K Cardiff Oncology, Inc. For: Sep 14
-
Form 424B5 SOUTHWESTERN ELECTRIC
-
Form 8-K BIOMARIN PHARMACEUTICAL For: Sep 10
-
Form 8-K Ellington Financial Inc. For: Sep 14
-
Form 424B2 UBS AG
-
Form D Frontier Commodities
-
Form 6-K Sony Group Corp For: Sep 14
-
Form 425 Medtronic plc Filed by: MiniMed Group, Inc.
-
Form 424B5 LANDWIRTSCHAFTLICHE RENT
-
Form 8-K HEALTHSTREAM INC For: Sep 10
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 424B2 CITIGROUP INC
-
Form 8-K Baldwin Insurance Group, For: Sep 14
-
Form D/A PvP Protocol Holding
-
Form X-17A-5 YORK STOCKBROKERS, INC. For: Jun 30
-
Form 8-K XBP Global Holdings, For: Sep 11
-
Form 6-K Castor Maritime Inc. For: Jun 30
-
Form 6-K Canaan Inc. For: Sep 14
-
Form 4 Anixa Biosciences Inc For: Sep 10 Filed by: Titterton Lewis H jr
-
Form N-CEN Alternative Strategies For: Jun 30
-
Form 424B2 CITIGROUP INC
-
Form 6-K SEALSQ Corp For: Jun 30
-
Form 4 TOWER SEMICONDUCTOR LTD For: Sep 10 Filed by: Chelouche Yoav
